Jacobs Levy Equity Management
AGN

Jacobs Levy Equity Management’s Allergan Inc AGN Stock Holding History

Jacobs Levy Equity Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-469,896
Closed -$52.2M – 1146
2013
Q4 		$52.2M Buy
469,896
+141,250
+43% +$13.5M 0.78% 12
2013
Q3 		$29.7M Buy
328,646
+201,363
+158% +$18.1M 0.5% 48
2013
Q2 		$10.7M Buy
+127,283
New +$13.2M 0.19% 156

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jacobs Levy Equity Management's AGN Position: Q1 2014 in Review

Jacobs Levy Equity Management sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 469,896 shares — an estimated $52.2M sold.

Jacobs Levy Equity Management first reported a position in AGN in Q2 2013 and held it in 3 quarters. The position peaked at $52.2M in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • Jacobs Levy Equity Management reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 469,896 Allergan Inc shares in Q1 2014, an estimated $52.2M.
  • Jacobs Levy Equity Management first reported a position in Allergan Inc in Q2 2013 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Allergan Inc position peaked at $52.2M in Q4 2013.
  • 733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.